ATNF

180 Life Sciences Corp. (ATNF)

About 180 Life Sciences Corp. (ATNF)

180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.

Details

Daily high

$2.02

Daily low

$1.86

Price at open

$1.98

52 Week High

$17.75

52 Week Low

$1.16

Market cap

994,500

Dividend yield

0.00%

Volume

54,547

Avg. volume

133,121

P/E ratio

-.39

180 Life Sciences Corp. News